$SNOWBullishMed

Software Was the Market's Big Laggard This Year. Snowflake's Blowout Might Be the Spark That Changes That.

Software stocks lagged early 2026 despite gains in the S&P 500, and Snowflake shares fell more than 50% from a year earlier in April. After fiscal Q1 ended April 30, Snowflake reported product revenue up 34% to $1.33B, non-GAAP operating margin rising to 12%, and EPS of $0.39. Management lifted full-year product revenue guidance to $5.84B and said AI is increasing data/workload consumption; Datadog and MongoDB also reported accelerating results.

9/10
6/10
Med
Bullish
after last week’s earnings reaction; positioning for follow-through vs valuation risk
bullish read-across from AI-driven reacceleration, but warns rebound may be priced

AI is framed as accelerating Snowflake consumption rather than disrupting it, supporting a valuation reset narrative.

Snowflake’s fiscal Q1 showed product revenue +34% YoY and management lifted full-year product guidance to $5.84B.

Near-term upside may be capped after a large post-earnings rebound, but the guidance/metrics support continued relative strength.

Background

The article argues early-2026 software weakness may have been overstated due to fears AI would disrupt software economics.

Why it matters

Snowflake’s reported acceleration (revenue, RPO, retention, customers) and raised guidance are presented as evidence that AI increases data/workload demand on existing platforms; Datadog and MongoDB are cited as similar beneficiaries.

Market relevance

Treat as a post-earnings read-through for AI-infrastructure software: reported acceleration and guidance lifts can drive near-term momentum, but valuation and consumption cyclicality raise downside if AI spend slows.

Market effects

Supports a software ‘AI beneficiary’ rotation narrative (data platforms, observability, databases) versus fears of AI displacement.

Primarily US large-cap software sentiment; limited direct regional specificity in the article.

AI infrastructure demand is global, but the article’s catalysts are company-specific partnerships and reported results.

Alternative perspectives

The rebound may be sentiment-driven: high valuation multiples and GAAP losses mean any cooling in AI consumption could quickly reverse the narrative.

Consumption-based revenue sensitivity to enterprise AI spend timing; also the article notes the rebound is already well advanced, reducing incremental upside.

Key entities

  • Snowflake

    Fiscal Q1 product revenue +34% YoY; strongest sequential dollar growth; raised full-year product revenue guidance; new $6B AWS five-year agreement; expanded OpenAI partnership.

  • Datadog

    Fiscal Q1 revenue +32% YoY; first billion-dollar quarter; raised full-year outlook.

  • MongoDB

    Fiscal Q1 revenue +25% YoY; Atlas up 29% and ~three-quarters of revenue; raised full-year guidance.

  • Amazon Web Services

    Named in Snowflake’s new $6B five-year agreement.

  • OpenAI

    Named in Snowflake’s expanded partnership.

Related articles

$DDOGMedAI 8/10

Stocks Retreat as US-Iran Peace Hopes in Doubt

US stocks retreated as markets scaled back hopes for US-Iran peace. US MBA mortgage applications fell 2.5% (purchase -2.9%, refi -2.3%); the 30-year fixed rate dropped 8 bp to 6.57%. The Fed Beige Book was hawkish, citing slight-to-moderate growth and higher inflation; John Williams said no rate change is needed. Traders priced a 3% chance of a 25 bp hike.

$RBRKMedAI 9/10

How Rubrik Stock Soared 47.9% Last Month

Rubrik shares rose 47.9% in May 2026, according to S&P Global Market Intelligence, with a 19.5% jump in the last two days. The move followed strong Q1 results from Snowflake, which investors said can lift related enterprise data software. Rubrik reported Q1 2027 revenue of $387 million (+39% YoY).

$MDBMedAI 9/10

MongoDB Is the Latest SaaS Apocalypse Victim to Say Not Today

MongoDB shares rose nearly 40% from pre-earnings levels after the company’s blowout earnings report last week, which the article says beat expectations across key metrics and reduced concerns that AI would hurt growth. It also notes analysts raised price targets afterward, with some projecting about 20% additional upside from current levels.

$TEAMMedAI 9/10

Stocks Pressured as Middle East Flare-Ups Boost Crude Oil

Overseas markets were mixed: Euro Stoxx 50 fell 0.63%, China’s Shanghai Composite rose 0.22%, and Japan’s Nikkei hit a record up 2.50%. US 10-year yields rose to 4.489% after US-Iran tensions pushed WTI up 1% and May ADP employment surprised higher. Stocks: software and private credit slid; chipmakers gained.